STRATTERA 5 MG TABLET is used in the management ofAtomosis, Hyperactivity and Impulsive Behavior (Hypertonia) that helps patients stop walking and stop falling asleepFor best results, the patient should take one tablet of STRATTERA 5 MG TABLET once daily with water.
Strattera 5 MG TABLET is not recommended for use in children and adolescents under the age of 18.
The most common side effects of taking STRATTERA 5 MG TABLET are constipation, nausea, headache, dizziness, and rash.
The most common side effects of taking STRATTERA 5 MG TABLET are dizziness, nausea, and fatigue.
The most common side effects of taking STRATTERA 5 MG TABLET are difficulty in sleeping, headache, and rash.
The most common side effects of taking STRATTERA 5 MG TABLET are skin rash, dizziness, abnormal heart beat, and priapism (prolonged and painful erection).
The most common side effects of taking STRATTERA 5 MG TABLET are feeling nervous, headache, stomach pain, and rash.
The most common side effects of taking STRATTERA 5 MG TABLET are diarrhea, constipation, nausea, vomiting, and rash.
The most common side effects of taking STRATTERA 5 MG TABLET are dizziness, muscle aches, and tenderness.
The most common side effects of taking STRATTERA 5 MG TABLET are nausea, fever, headache, and vomiting.
The most common side effects of taking STRATTERA 5 MG TABLET are skin rash, dizziness, muscle aches, tenderness, and rash.
The most common side effects of taking STRATTERA 5 MG TABLET are fever, headache, stomach pain, and rash.
The most common side effects of taking STRATTERA 5 MG TABLET are nausea, nausea, vomiting, and rash.
The most common side effects of taking STRATTERA 5 MG TABLET are muscle aches, tenderness, and rash.
The most common side effects of taking STRATTERA 5 MG TABLET are fever, headache, and stomach pain.
The most common side effects of taking STRATTERA 5 MG TABLET are constipation, nausea, vomiting, and rash.
Strattera is a prescription medicine to treat patients with a mental disorder called attention-deficit hyperactivity disorder (ADHD). It belongs to a class of drugs called selective norepinephrine reuptake inhibitors and contains the active ingredient atomoxetine. It is used as a part of an ADHD treatment program which includes psychological, educational, social, and other treatments. It is approved for use in adults and children above 6 years of age.
Strattera is used to treat symptoms of attention-deficit hyperactivity disorder (ADHD). ADHD is a chronic condition that commonly occurs in children and teenagers and can continue into adulthood. ADHD symptoms include attention difficulty, hyperactivity, impulsiveness, irritability, anxiety, mood swings, depression, and learning disability.
Strattera works by restoring the levels of certain chemicals in the brain linked to ADHD such as norepinephrine and dopamine. This helps to increase attention, and reduce hyperactivity and impulsive behavior in the patients.
During treatment with Strattera, patients may experience some common side effects, including:
Patients taking Strattera may have some serious side effects that require urgent medical attention, including:
Strattera comes in the form of capsules in different strengths:10mg, 18mg, 25mg, 40mg, 60mg, 80mg, and 100mg. It is usually taken orally 1 to 2 times a day, with or without food. The first dose can be taken in the morning and the second dose in the evening. Take the medication regularly at the same time for maximum benefits.
The recommended starting dose of Strattera for adults with ADHD is 40mg a day orally. The recommended starting dose for pediatric patients with ADHD is 0.5mg/kg/day (70 kg or less) and 40mg/day (over 70 kg).
Patients should be aware that Strattera can cause serotonin syndrome, a medical condition that affects the nerves in the brain that line the brain. The affected nerves then become serotonin-norepinephrine syndrome.
Patients should also speak to their doctor if they continue using Strattera and have severe side effects:
MVPs for:
All patients with ADHD/QTc disorders should have Strattera prescribed by a doctor. The doctor will determine the appropriate dosage and for each patient.
Patients should also speak to their doctor if alcohol or other central nervous system medicines or other psychiatric conditions cause the side effects listed above or if any of the other drugs they are using may interact with Strattera.
This report covers information on drug abuse, abuse of illegal drugs, and the treatment of children and adolescents. You may need to review the following articles carefully before you start using the report.
The FDA has approved the use ofamphetamine/dextroamphetamine(dextroamphetamine) in the treatment of both amphetamine-induced and amphetamine-non-induced depression and in the treatment of both amphetamine-induced and amphetamine-non-induced seizures.
In 2008, the US Food and Drug Administration (FDA) approved the use ofin the treatment of both amphetamine-induced and amphetamine-non-induced depression. This medication is known as the “” product. In 2005, the drug was approved for the treatment of both amphetamine-induced and amphetamine-non-induced depression and for the treatment of both amphetamine-induced and amphetamine-non-induced seizures. Since then, the FDA has approved the use ofin the treatment of both amphetamine-induced and amphetamine-non-induced depression and for the treatment of both amphetamine-induced and amphetamine-non-induced seizures. This is the most common treatment for both amphetamine-induced and amphetamine-non-induced depression.
This drug is also known as the “In 2003, the FDA approved the use ofin the treatment of both amphetamine-induced and amphetamine-non-induced seizures.
A 2004 study showed that there is an increased risk of drug abuse and dependence when usingfor the treatment of both amphetamine-induced and amphetamine-non-induced depression.
A 2006 study showed that the use ofis associated with an increased risk of drug abuse and dependence. The study included over 500,000 people aged 16 to 60 years.
A 2006 study was the largest study to evaluate the use of
In 2007, the FDA approved the use ofThis is the second FDA approval of the use of
This report will focus on the use ofin the treatment of both amphetamine-induced and amphetamine-non-induced depression and in the treatment of both amphetamine-induced and amphetamine-non-induced seizures.
In 2006, the US Food and Drug Administration (FDA) approved the use ofThe use ofis known as the “In 2005, the drug was approved for the treatment of both amphetamine-induced and amphetamine-non-induced depression.
Atomoxetine, marketed under the brand name Strattera, is a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). It belongs to a class of drugs known as selective norepinephrine reuptake inhibitors (SNRIs). The drug works by increasing the levels of norepinephrine, which helps improve attention span, focus, and impulse control. Atomoxetine is available in various forms and dosages.
Strattera is the generic name of atomoxetine, which is used to treat ADHD. It is available in both tablet and liquid form. The FDA-approved drug Strattera is also used to treat depression and other mood disorders.
Atomoxetine is available in multiple forms and dosages, including capsules, tablets, and oral suspension. The FDA approved drug is also available in oral suspension for children and adults. It is not approved for the treatment of ADHD.
Strattera belongs to a class of medications called atypical antipsychotics. It works by increasing levels of norepinephrine in the brain. This increase in norepinephrine helps improve attention span, impulse control, and impulse control in people with ADHD.
The drug is metabolized primarily by the liver. It is excreted primarily by the kidneys. The drug is excreted unchanged in the urine, primarily in the form of a powder. The metabolites of atomoxetine are N-desmethyl and N, N-dimethyl atomoxetine. The most common metabolites of atomoxetine are N, N-diethyl-N-desmethyl-and N, N-dimethyl-N-desmethyl-tetrahydro-N, N-diethyl-N, N-tetrahydrofurantoin.
Atomoxetine is available in several forms and dosages:
Strattera is generally well-tolerated. However, some side effects may occur. Common side effects may include:
Other serious side effects may include:
It is important to monitor for any unusual symptoms during treatment. If the symptoms persist or worsen, it is advisable to discontinue the medication.
Atomoxetine is metabolized primarily by the liver, and the drug should not be taken with any other medications. It is also contraindicated for people who have a history of drug abuse or mental disorders.
The drug should not be used with other antidepressants or mood stabilizers because the combination may cause a dangerous drop in blood pressure. A dose adjustment is recommended if these medications are combined.
It is important to note that atomoxetine should not be taken with monoamine oxidase inhibitors (MAOIs).
It is important to discuss any drug interactions with other medications you are taking with your healthcare provider. If you experience symptoms of depression, especially agitation or irritability, contact your healthcare provider.
Athlete's foot is a common condition that affects millions of people worldwide. Fortunately, there is no cure for this condition, but there is a way to treat your symptoms.
Strattera is a medication that works by increasing the levels of certain natural substances in the body. It can also be used to treat some conditions such as attention deficit hyperactivity disorder (ADHD) and narcolepsy, which are conditions that affect both the mind and the body.
The active ingredient in Strattera is atomoxetine, a non-stimulant. Atomoxetine belongs to the class of drugs called selective norepinephrine reuptake inhibitors. It works by increasing the levels of certain natural substances in the body. It can help improve attention span, concentration, and hyperactivity, which are two symptoms that can lead to problems in relationships and work to improve a man's self-esteem.
The most common side effects of Strattera include nausea, drowsiness, dry mouth, headache, constipation, insomnia, and dizziness. If you have taken Strattera before, talk to your doctor about the possibility of experiencing withdrawal symptoms if you stop taking the medication.
Before taking Strattera, it is important to know about the possible side effects of its use. Some of the common side effects of Strattera include:
If you experience any of these side effects, tell your doctor immediately. They may adjust the dosage or prescribe an alternative medication. It is important to seek advice from your doctor before starting Strattera to ensure that the drug is safe for you.
You should not take Strattera if you have any of the following conditions:
If you are unsure whether Strattera is right for you, talk to your doctor or pharmacist before taking it. They will be able to advise you on the best course of action and potential side effects. They will be able to recommend the most suitable medication for you to take Strattera.
There are some rare but serious side effects of Strattera.
Stade de France Pharmacy